ACEI/ARB therapy in COVID-19: the double-edged sword of ACE2 and SARS-CoV-2 viral docking | Critical Care | Full Text
Frontiers | Role of Renin-Angiotensin System Components in Atherosclerosis: Focus on Ang-II, ACE2, and Ang-1–7
Coronavirus Disease 2019 (COVID‐19) and Cardiovascular Disease: A Viewpoint on the Potential Influence of Angiotensin‐Converting Enzyme Inhibitors/Angiotensin Receptor Blockers on Onset and Severity of Severe Acute Respiratory Syndrome Coronavirus 2 ...
A Pair of “ACEs” - E.V. Hersh, M. Wolff, P.A. Moore, K.N. Theken, H. Daniell, 2022
Repurposing of approved drugs with potential to interact with SARS-CoV-2 receptor - ScienceDirect
Drugs that mimic effects of cigarette smoke reduce SARS-CoV-2's ability to enter cells | Hiroshima University
What is the ACE2 receptor, how is it connected to coronavirus and why might it be key to treating COVID-19? The experts explain
Identification of an existing Japanese pancreatitis drug, Nafamostat, which is expected to prevent the transmission of new coronavirus infection (COVID-19) | The University of Tokyo
Angiotensin-Converting Enzyme 2, Feedback Systems, and COVID-19 | Consultant360
Antihypertensive drugs and risk of COVID-19? - The Lancet Respiratory Medicine
Human recombinant soluble ACE2 (hrsACE2) shows promise for treating severe COVID19 | Signal Transduction and Targeted Therapy
The Two Faces of ACE2: The Role of ACE2 Receptor and Its Polymorphisms in Hypertension and COVID-19 - ScienceDirect
![Angiotensin Converting Enzyme 2 in Coronavirus Disease (COVID-19): Evidence from Bioinformatics Analysis[v1] | Preprints.org](https://www.preprints.org/img/dyn_abstract_figures/2020/04/93d4f3205ba45f799eaed16b6090a168/preprints-26839-Graphic%20abstract%20submit.jpg "Angiotensin Converting Enzyme 2 in Coronavirus Disease (COVID-19): Evidence from Bioinformatics Analysis[v1] | Preprints.org")
Angiotensin Converting Enzyme 2 in Coronavirus Disease (COVID-19): Evidence from Bioinformatics Analysis[v1] | Preprints.org
![In Search for Effective and Safe Drugs Against SARS-CoV-2: Part I] Simulated Interactions Between Selected Nutraceuticals, ACE2 Enzyme and S Protein Simple Peptide Sequences | Theoretical and Computational Chemistry | ChemRxiv](https://chemrxiv.org/engage/api-gateway/chemrxiv/assets/orp/resource/item/60c74a31ee301cd8dbc79bf1/largeThumb/in-search-for-effective-and-safe-drugs-against-sars-co-v-2-part-i-simulated-interactions-between-selected-nutraceuticals-ace2-enzyme-and-s-protein-simple-peptide-sequences.jpg "In Search for Effective and Safe Drugs Against SARS-CoV-2: Part I] Simulated Interactions Between Selected Nutraceuticals, ACE2 Enzyme and S Protein Simple Peptide Sequences | Theoretical and Computational Chemistry | ChemRxiv")
In Search for Effective and Safe Drugs Against SARS-CoV-2: Part I] Simulated Interactions Between Selected Nutraceuticals, ACE2 Enzyme and S Protein Simple Peptide Sequences | Theoretical and Computational Chemistry | ChemRxiv
ACE inhibitor - Wikipedia
ACE2 - Der SARS-CoV-2 Rezeptor | Biomol Blog | Ressourcen | Biomol GmbH - Life Science Shop
ACE2: Targeting a Potentially Important Receptor in Disease Pathogenesis | CAS
Dalbavancin binds ACE2 to block its interaction with SARS-CoV-2 spike protein and is effective in inhibiting SARS-CoV-2 infection in animal models | Cell Research
Role of ACE2 receptor and the landscape of treatment options from convalescent plasma therapy to the drug repurposing in COVID-19 | Molecular and Cellular Biochemistry
Determining available strategies for prevention and therapy: Exploring COVID‑19 from the perspective of ACE2 (Review)
Interactions of coronaviruses with ACE2, angiotensin II, and RAS inhibitors—lessons from available evidence and insights into COVID-19 | Hypertension Research
